My bossy GP has cut my thyroid pills – and it’s left me exhausted

MAIL ONLINE – ASK THE DOCTOR
A patient complains that with the cutting of their dosage symptoms of low thyroid have returned. The doctor’s response includes this paragraph:
 I recall a key lesson taught to me years ago when taking my postgraduate exams. Dr Maurice Pappworth, one of the greatest medical teachers of the past century, used to say that when it came to supplementing the thyroid hormone, ‘treat the patient and not the lab result’ – take into account how the patient feels and do not merely focus on figures on a report.

Thyroid – the correct prescribing of thyroid hormones

Thyroid – the correct prescribing of thyroid hormones

There are four reasons why UK citizens are not subject to “best practice” with respect to prescribing thyroid hormones. All relate to the prescribing of thyroid hormone for underactive thyroid glands (hypothyroidism).

The threshold for thyroid stimulating hormone (TSH) is set too high.

When levels of thyroid hormones in the blood start to fall, the pituitary gland increases its output of thyroid stimulating hormone (TSH), which kicks the thyroid into life and increases output of thyroid hormones. If the thyroid gland starts to fail, this is reflected by levels of TSH rising. The question is at what point should the prescription of thyroid hormones begin?

The normal range for TSH in this country varies enormously from one laboratory to another. This means in some locations in the UK a thyroid prescription would not be given until the TSH rose above 5.0mlU/l.

As a result of research, the normal range for TSH in America has now been reduced so that anybody with a TSH above 3.0 is now prescribed thyroid hormones. This research has shown that people with a TSH above 3.0 are at increased risk of arterial disease (a major cause of death in Western culture), insulin resistance (and therefore diabetes), inflammation and hypercoagulability (sticky blood). Indeed, there is a recommendation afoot in America to further reduce the threshold for prescribing to 2.5mlU/l.

What is completely illogical is that in UK the target TSH level for patients on thyroid replacement therapy is often stated as being less than 2 or even less than 1.5. This is a ridiculous anachronism!

We should reduce the threshold for prescribing thyroid hormones to <3.0mlU/L or better still 2.5mlU/l.

There is a further inconsistency in BTS guidelines. The level of thyroid hormones in pregnancy is critical for foetal development. For pregnancy the target for TSH is a level below 2.5mlU/L. Furthermore requirements during pregnancy increase, so thyroid function should be checked every three months. What is the logic of only prescribing thyroid hormones to a non-pregnant woman with a TSH of above 5.0 but if pregnant 2.5?

Population normal range versus individual normal range – they are not the same

The population normal range for levels of thyroid hormone in the blood is not the same as the individual normal range. We differ as individuals in our biochemistry as we differ in our looks, intelligence and morphology. This biochemical variation should be taken into account when it comes to prescribing thyroid hormones.

The population normal range of a Free T4 is 12 – 24pmol/L. A patient, therefore, with blood levels of 12.1 would be told they were normal because they are within the population reference range. But actually that person’s personal normal range may be high. They may feel much better running a high T4 of say 22, i.e. nearly twice as much but still within the population reference range.

Research done originally in UK, and now repeated in America, clearly shows that the individual normal range of thyroid hormones is not the same as the population reference range. In order to find out who these individuals are, patients have to be assessed clinically as well as biochemically. In actual UK clinical practice this is rarely done except by a few physicians conversant with this issue.

Some people feel better on different preparations of thyroid hormones

In theory, if the patient has been shown to be hypothyroid, then all their symptoms should be improved with synthetic sodium thyroxine. In practice, this is not always the case – there is no doubt that clinically some patients feel very much better taking biologically identical hormones such as natural thyroid (a dried extract of pig thyroid gland which is a mix of T4 and T3). Indeed, before synthetic thyroid hormones became available, all patients were routinely treated with natural thyroid. The purity and stability of these preparations has been long established, indeed much longer than synthetic thyroxine!

Part of the reason why people feel better taking natural bio-identical hormones is that some people are not good at converting T4 (which is relatively inactive) to T3 (which is biologically active). However, this does not explain the improvement in every case. It is difficult to explain why there should be an additional effect, but for many people it is the difference between drinking cheap French plonk and good quality Spanish Rioja. The alcohol content is the same, but the experience completely different!

According to Dr A Toft, Consultant Endocrinologist, Edinburgh, “It would appear that the treatment of hypothyroidism is about to come full circle.”

“In patients in whom long-term T4 therapy was substituted by the equivalent combination of T3 and T4 scored better in a variety of neuropsychological tests. It would appear that the treatment of hypothyroidism is about to come full circle”. Ref: Endocrine Abstracts 3 S40, T3/T4 combination therapy. AD Toft, Endocrine Clinic, Royal Infirmary, Edinburgh, UK.

Some people only feel well using pure T3

At present we do not have biochemical tests to predict who these people are! A reverse T3 test may help but may not. If symptoms are typical of hypothyroidism but not responding to T4 or T4/T3 mixes, then a trial of pure T3 may be in order. T3 is short acting and must be taken at least 3, possibly 5 times daily. The smallest size tablet is prescription only tertroxin 20mcgms (equivalent to 100mcgms of T4). A starting dose would be 10mcgms split into 3 doses – tricky! I suggest crushing half a tablet, and using a wet finger tip to take a third of the powder three times daily. One may know within a few days if this was making a difference but a proper trial would be a few weeks. For details, see Paul Robinson’s excellent book on the subject – Recovering with T3: My Journey from Hypothyroidism to Good Health Using the T3 Thyroid Hormone.

For more detailed discussion see[[1]] where the importance of pure T3 is explained in terms of transport of T3 across cell membranes.

The timing of dosing may be critical

Paul Robinson, in his excellent book T3 hypothyroidism, has made the interesting observation that our circadian rhythms, essential to health, are determined by when hormones are produced. Since they work synergistically we need them to be produced at the same time. Timing is triggered by the pituitary gland, the conductor of the endocrine orchestra! It starts with TSH levels rising sharply at midnight and is followed by increases in T4, T3 and cortisol later in the night. As they come together they trigger wakefulness. Paul found out for himself, and proved it to his satisfaction through blood tests, that his health was further improved by taking his morning dose of T3 at 5.30am. See his website [[2]] for his account of this.

Monitoring treatment just by using a TSH can be misleading

In his article (follow the link below in Related Articles) Peter Warmingham cogently explains how just a TSH is not a good way to monitor replacement therapy. It is vital to measure levels of free T4, ideally free T3 as well, and assess the patient clinically – ie how do they feel? Are there any clinical symptoms of under or over dosing?

Finally anyone who is hypothyroid for reasons other than autoimmunity, is likely to be iodine deficient. See Iodine – what is the correct daily dose?

Why are we seeing an epidemic of thyroid disease?

A whole range of chemicals have been shown to be goitrogenic and/or suppressors of the HPA axis and/or suppressors of thyroid hormones uptake and/or suppressors of T3 uptake. These include perchlorates (washing powder), phthalates and bisphenol A (in plastic wrappings), pyridines (cigarette smoke), PCBs and PBBS(fire retardants in soft furnishing), UV screens (sunblocks and cosmetics), and many others. For a full list see http://oted.oxfordmedicine.com/cgi/content/abstract/2/1/med-9780199235292-chapter-322

Related Articles

Related Tests

Thyroid profile: free T3, free T4 and TSH

This article has been taken, with her permission, from the website of Dr Sarah Myhill.   (Bolding by HCS)

http://drmyhill.co.uk/drmyhill/index.php?title=Thyroid_-_the_correct_prescribing_of_thyroid_hormones&printable=yes

Integrative Medicine in Thailand – Medical Tourism

Follow these links to see some of the integrative medical work, including bioidentical hormone replacement therapy, available in Thailand.

http://www.thailandmedtourism.com/TreatmentCat/50/Holistic-Anti-aging

From Bangkok Hospital:

http://www.placidway.com/article/156/Staying-Young-With-Bangkok-Hospital/

http://www.intellihealthplus.com/therapy-treatments/bioidentical-hormone-therapy

From Bumrungrad Hospital:

http://www.e-vitallife.com/news/83/97/Hormones-Get-the-balance-right-for-better-living.html

Evidence Based Concept – Dr Bill Reeder

Evidence Based Concept

It is standard medical policy to judge treatments based on EBM, or ‘evidenced based medicine’. This term is laudable and reflects the need to protect the patient from potential harm and to provide proven, safe treatments.

Unfortunately the concept can be used by self-interest parties to shut down very worthwhile treatments which have an excellent record of benefit, minimal if any harm – but lack the much touted RCT – randomised clinical trial. Such trials are extremely expensive and almost exclusively confined to pharmaceutical chemicals.

Small trials, evidence from case studies and observation over time can be valid parameters of evidence. We are only too aware of the EBM drugs that have taken a toll on morbidity and mortality – to be eventually withdrawn from the market and not too promptly I should add.

So the EBM model is a good concept but must be used wisely – not as a political device.

“Ultimately, medicine has a single aim: to relieve human suffering and promote wellness. When measured against this benchmark, different therapies should be seen on a spectrum ranging from effective to ineffective rather than as ‘orthodox, mainstream’ or ‘unorthodox, non-mainstream’. More so, any therapy choice should cause least, preferably, no harm. These two themes must influence treatment choices.

No single professional group has ownership of health, and the best healthcare requires a multidisciplinary approach. Thus there is an imperative for all healthcare professionals to work together for the benefit of their patients and the wider community – prejudices should be cast aside.”

This well balanced discussion of the use of evidence based medicine is taken from the website of Dr Bill Reeder, an integrative practitioner in New Zealand. http://www.medcom.co.nz/

The Bioidentical Hormone Debate: Are Bioidentical Hormones (Estradiol, Estriol, and Progesterone) Safer or More Efficacious than Commonly Used Synthetic Versions in Hormone Replacement Therapy? Dr Ken Holtorf

Follow this link to Dr Ken Holtorf’s article, which is rather long but the conclusion of which is positive with regard to bioidentical hormone replacement therapy:

A thorough review of the medical literature supports the claim that bioidentical hormones have some distinctly different, often opposite, physiological effects to those of their synthetic counterparts. With respect to the risk for breast cancer, heart disease, heart attack, and stroke, substantial scientific and medical evidence demonstrates that bioidentical hormones are safer and more efficacious forms of HRT than commonly used synthetic versions. More randomized control trials of substantial size and length will be needed to further delineate these differences.

http://jeffreydachmd.com/wp-content/uploads/2014/07/The_Bioidentical_Hormone_Debate_Ken_Holtorf_MD-3.pdf

Animal Thyroid Extract as Effective as T4 in Treating Hypothyroidism

Study opens door for additional treatment option for common thyroid disorder

SAN FRANCISCODesiccated thyroid extract (DTE), derived from crushed preparations of animal thyroid glands, is a safe and effective alternative to standard T4 therapy in hypothyroid patients [bolding by HCS], a new study finds. The results were presented Monday at The Endocrine Society’s 95th Annual Meeting in San Francisco.  [June 15-18, 2013]

In adults, untreated hypothyroidism leads to poor mental and physical performance. It also can cause high blood cholesterol levels that can lead to heart disease. The condition is treated with Levothyroxine, a synthetic (laboratory-made) form of T4 that is identical to the T4 the thyroid naturally makes. Before the advent of synthetic thyroxine, patients with hypothyroidism were treated with DTE, which contains both T4 and the active thyroid hormone T3. Many patients claim they do not feel as well on T4 alone without the additional T3 hormone.

“While thyroid experts recommend T4 alone for treatment of hypothyroidism, until now there have not been any randomized double-blind studies to compare the clinical effectiveness of synthetic T4 with DTE,” said Thanh Hoang, of the Naval Medical Center in Portsmouth, Virginia. “We found that DTE is a safe and effective alternative to the standard T4 therapy. Furthermore, DTE caused modest weight loss compared to T4 alone.”

In this study, researchers investigated the effectiveness of DTE compared to Levothyroxine (L-T4) in 70 hypothyroid patients. Patients were randomized to either DTE or L-T4 for 16 weeks and then crossed-over for the same duration. Study subjects underwent biochemical and neurocognitive tests along with measurements of symptoms and mental health at baseline and at the end of each treatment period.

DTE therapy did not result in a significant improvement in quality of life, but did cause modest weight loss and nearly half of the study patients expressed preference for DTE over L-T4.

Posted with permission from The Endocrine Society, Washington DC

https://www.endocrine.org/news-room/press-release-archives/2013/animal-thyroid-extract-as-effective-as-t4-in-treating-hypothyroidism

 

 

A Comprehensive Review of the Safety and Efficacy of Bioidentical Hormones for the Management of Menopause and Related Health Risk

Follow the link below to:

A Comprehensive Review of the Safety and Efficacy of Bioidentical Hormones for the Management of Menopause and Related Health Risk

Deborah Moskowitz, ND

Alternative Medicine Review, Volume 11, November3, 2006

http://www.altmedrev.com/publications/11/3/208.pdf

The author shows that bioidentical hormone preparations have demonstrated effectiveness in addressing menopausal symptoms, advocates for continued research on bioidentical hormones and concludes there is currently sufficient evidence to support their preferred use over that of their synthetic cousins.

Effectiveness of Compounded Bioidentical Hormone Replacement Therapy: An Observational Cohort Study

Follow the link below to:

Effectiveness of Compounded Bioidentical Hormone Replacement Therapy: An Observational Cohort Study

Andres D Ruiz, Kelly R Daniels, Jamie C Barner, John J Carson and Christopher R Frei

BMC Women’s Health 2011, 11-27

http://www.biomedcentral.com/content/pdf/1472-6874-11-27.pdf

This was an observational study of women between the ages of 18-89 who received a compounded BHRT product from January 1, 2003 to April 30, 2010 in six community pharmacies. It demonstrates that compounded BHRT improves mood symptoms. Larger studies are needed to examine the impact on vasomotor symptoms, myocardial infarction and breast cancer.

 

 

 

Bioidentical Hormones: An Evidence-Based Review for Primary Care Providers

Follow the link below to:

Bioidentical Hormones: An Evidence-Based Review for Primary Care Providers

Journal of the  American Osteopathic Association, March 1, 2011 vol. 111 no. 3 153-164                           

http://jaoa.org/article.aspx?articleid=2094168

A thorough, well balanced  review of Bioidentical Hormone Therapy, which concludes that “Bioidentical hormone therapy supported with sufficient trial data—including estrone, 17β-estradiol, and progesterone—offers a favorable adverse effect profile over HRT and is equally effective in managing menopausal symptoms. Further studies are needed in order to prove the safety and efficacy of estriol, DHEA, and testosterone in women. Additionally, long-term studies are needed to assess the safe duration of use of all BHT.”